Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study
'Recurrent brief depression' (RBD) is a common, distressing and impairing depressive disorder for which there is no current proven pharmacological or psychological treatment. This multicentre, randomized, fixed-dose, parallel-group, placebo-controlled study of the reversible inhibitor of monoamine oxidase moclobemide (450?mg/day) and the tricyclic antidepressant imipramine (150?mg/day) evaluated the potential efficacy of active medication, when compared with placebo, in patients with recurrent brief depression, recruited in the mid-1990s. After a 2-4-week single-blind placebo run-in period, a total of 35 patients were randomized to receive double-blind medication for 4 months, but only 16 completed the active treatment period. An intention-to-treat analysis of the 34 evaluable patients found no evidence for the efficacy of moclobemide or imipramine, when compared with placebo, in significantly reducing the severity, duration or frequency of depressive episodes. A total of 28 patients experienced at least one adverse event, and four patients engaged in nonfatal self-harm. Limitations of the study include the small sample size and the high rate of participant withdrawal. The lack of efficacy of these antidepressant drugs and the previous finding of the lack of efficacy of the selective serotonin reuptake inhibitor fluoxetine together indicate that medications other than antidepressant drugs should be investigated as potential treatments for what remains a common, distressing and potentially hazardous condition.
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Green, M.
23f60752-38ff-409a-a5f7-bf3c15d0eb67
Montgomery, S.A.
8b3324f3-c514-4f9d-9c33-6af1824da849
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Green, M.
23f60752-38ff-409a-a5f7-bf3c15d0eb67
Montgomery, S.A.
8b3324f3-c514-4f9d-9c33-6af1824da849
Baldwin, D.S., Green, M. and Montgomery, S.A.
(2014)
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
International Clinical Psychopharmacology.
(doi:10.1097/YIC.0000000000000042).
(PMID:24859491)
(In Press)
Abstract
'Recurrent brief depression' (RBD) is a common, distressing and impairing depressive disorder for which there is no current proven pharmacological or psychological treatment. This multicentre, randomized, fixed-dose, parallel-group, placebo-controlled study of the reversible inhibitor of monoamine oxidase moclobemide (450?mg/day) and the tricyclic antidepressant imipramine (150?mg/day) evaluated the potential efficacy of active medication, when compared with placebo, in patients with recurrent brief depression, recruited in the mid-1990s. After a 2-4-week single-blind placebo run-in period, a total of 35 patients were randomized to receive double-blind medication for 4 months, but only 16 completed the active treatment period. An intention-to-treat analysis of the 34 evaluable patients found no evidence for the efficacy of moclobemide or imipramine, when compared with placebo, in significantly reducing the severity, duration or frequency of depressive episodes. A total of 28 patients experienced at least one adverse event, and four patients engaged in nonfatal self-harm. Limitations of the study include the small sample size and the high rate of participant withdrawal. The lack of efficacy of these antidepressant drugs and the previous finding of the lack of efficacy of the selective serotonin reuptake inhibitor fluoxetine together indicate that medications other than antidepressant drugs should be investigated as potential treatments for what remains a common, distressing and potentially hazardous condition.
This record has no associated files available for download.
More information
Accepted/In Press date: May 2014
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 368015
URI: http://eprints.soton.ac.uk/id/eprint/368015
ISSN: 0268-1315
PURE UUID: 69da5ef5-ebd3-45aa-b4f7-e799934f8397
Catalogue record
Date deposited: 29 Aug 2014 13:35
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
M. Green
Author:
S.A. Montgomery
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics